Magnetic Resonance Imaging (MRI) of the Brain and Spine: Basics: Magnetic resonance imaging (MRI) is one of the most commonly used tests in neurology and neurosurgery.MRI provides exquisite detail of ...

For suspected axial spondyloarthritis, preliminary data from a study suggested MRI or CT of the sacroiliac joints were better first-line imaging choices than radiographs. News & Perspective Tools ...

Axial Therapeutics’ Scientific Founder Sarkis Mazmanian, Ph.D., to Present Research Highlighting the Gut-Brain Connection in Autism Spectrum Disorder (ASD) at TACA’s Autism Action Conference ...

T2 imaging of the fetal brain was performed in axial, coronal and sagittal planes at a slice thickness of 3 to 4 mm and field of view of 30 mm. Postnatal MRI was obtained at term equivalent age ...

Introduction To investigate if increased Tibial tubercle – Trochlear Groove distance (TT-TG) measured on axial MRI is due to lateralization of the tibial tubercle or medialization of the trochlear ...

With over 40 million United States adults impacted by anxiety disorders, people are hungry for actionable tips and approachable tools. Seed Health has partnered with Axial Therapeutics to develop ...

Axial Biotherapeutics is the latest startup working to manipulate the microbiome as a means to treat disease. The Caltech spin-out just announced $19.15 million in Series A funding to tackle a ...

Axial Biotherapeutics has raised $25 million to fund its programs aimed at the gut microbiome, for the treatment of Parkinson’s disease and autism spectrum disorder.

In patients with non-radiographic axial spondyloarthritis, MRI sacroiliitis and HLA-B27 positivity, but not elevated C-reactive protein or responses at week 12, predict long-term certolizumab ...

Building on a decade of research, the program will develop next-generation probiotics and therapeutics to modulate the gut microbiota to target areas like anxiety, depression and mental well-being LOS ...

LOS ANGELES and BOSTON, July 13, 2022 /CNW/ -- Seed Health, a microbiome science company, and Axial Therapeutics, a clinical-stage biopharmaceutical company, today announced a joint development ...